FDA approves Datroway for HR-positive, HER2-negative breast cancer
The U.S. Food and Drug Administration has approved Datroway (datopotamab deruxtecan-dlnk) for adult patients with ...
Metastatic Breast Cancer FDA Approvals, Clinical Trials Assessment, Pipeline Insights and Companies | DelveInsight
DelveInsight’s, “Metastatic Breast Cancer Pipeline Insight” report provides comprehensive insights about 100+ companies and ...
Alpha Tau Announces Cornerstone Interim Data Across Multiple Clinical Trials to be Shared at R&D Update Day
High disease control rate and strong interim safety results observed in pancreatic cancer patients across three trials exploring the use of ...
Alpha Tau receives IDE from FDA for study evaluating Alpha DaRT, chemo combo
The company also announced the receipt of an IDE from the U.S. Food and Drug Administration, to conduct a clinical study examining the ...